Navigation Links
BioNeutral Laboratories Announces the Appointment of Stephen Browand as a Director to Head Military, Homeland Security and Governmental Affairs
Date:6/25/2008

NEWARK, N.J., June 25 /PRNewswire/ -- BioNeutral announced today that Steve Browand will direct the company's efforts to sell its advanced chemical technology products to the military, Homeland Security and governmental departments. Steve Browand said, "I have reviewed the test results announced by Dr. Tierno, regarding anthrax, the attached video interview with Dr. Kielbania and Dr Tierno and the performance of the company's formulations in combating chemical and biologic threats and I believe it to be world-class. I will be meeting with military and government officials who have conveyed their interest in this powerful next-generation defensive tool."

YouTube link: http://www.youtube.com/watch?v=FOlnXLp1Itg

"Mr. Browand's extensive security and diverse business experience spans over 30 years from multiple sectors, including military, municipal and private. He started his career as an intelligence officer serving in the European theatre, where he gained experience in the areas of vulnerability analysis, counter-terrorism, strike contingency planning, emergency management and the deployment of counter-intelligence safeguards. This experience has enabled Mr. Browand to add considerable value to our company," said Raj Pamani, Director of BioNeutral.

About BioNeutral Laboratories Corporation

BioNeutral was organized in 2003 to commercialize a novel combinational chemistry-based technology that can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses and spores. The formulations are "Green" and include natural and common ingredients which are found in baby products and the foods we eat. These widely used compounds are combined in unique ways to create enhanced results.

BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. The products include BioNeutralizers and ChemoNeutralizers. BioNeutralizers disinfect, decontaminate and sterilize. BioNeutral believes it has the broadest-based, fastest-acting, most effective and safest antimicrobial known. This class of products has important applications for consumers, healthcare and the military. ChemoNeutralizers irreversibly bind chemical contaminant and toxin molecules and render them harmless. Product applications include industrial pollution and protection against chemical weapons of mass destruction.

About Dr. Philip Tierno

Dr. Tierno is a consultant to BioNeutral. He is the Director of Clinical Microbiology and Diagnostic Immunology at Tisch Hospital, New York University Medical Center. He is also an Associate Professor at the New York University School of Medicine, NYU College of Dentistry and SUNY School of Optometry in New York City. Dr. Tierno is a member of the NYC Mayor's MRC (Medical Reserve Corps) and a former member of New York City's task force on bioterrorism. Dr. Tierno's work in the field of microbiology has resulted in numerous articles and texts that have been published in medical and scientific journals. He is co-editor and author of several books on microbes and biological protection.

Contact:

Info@bioneutralgroup.com

Stephen J. Browand

Director

Governmental Affairs

steve@bioneutralgroup.com

Dr. Philip Tierno

Consultant

philip.tierno@nyumc.org

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE BioNeutral Laboratories Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. BioNeutral Announces a BREAKTHROUGH in the Fight Against Bioterrorism
2. ARUP Laboratories ARUP Consult(R) Recognized as a Computerworld Honors Program Laureate
3. Frontage Laboratories Completes Acquisition of Advanced Biomedical Research, Inc. (ABR)
4. Barrier Therapeutics to Merge Into Stiefel Laboratories
5. ARUP Laboratories Partners With Pathology Service Associates
6. Fontus Pharmaceuticals Acquires Nephrology and Endocrinology Drug from Roche Laboratories Inc.
7. Cato Research and Neuland Laboratories Form Cato Research Neuland India, Ltd.
8. Forest Laboratories, Inc. and Laboratorios Almirall, S.A. to Host Webcast to Discuss Aclidinium Bromide Data Presentations at the American Thoracic Society Annual Congress
9. Forest Laboratories, Inc. and Daiichi Sankyo, Inc. Announce the Termination of the AZOR Co-Promotion Agreement
10. IDEXX Laboratories Announces First Quarter Results
11. ARUP Laboratories CEO and Co-Founder Announces Retirement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016  Blueprint Bio, a company ... to the medical community, has closed its Series A ... Nunez . "We have received a commitment ... capital we need to meet our current goals," stated ... us the runway to complete validation on the current ...
(Date:6/23/2016)... Francisco, CA (PRWEB) , ... June 23, 2016 ... ... (EDC) software, is exhibiting at the Pennsylvania Convention Center and will showcase its ... Annual conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical ...
(Date:6/23/2016)... , June 22, 2016  Amgen (NASDAQ: ... of the QB3@953 life sciences incubator to ... health. The shared laboratory space at QB3@953 was created ... a key obstacle for many early stage organizations - ... of the sponsorship, Amgen launched two "Amgen Golden Ticket" ...
(Date:6/22/2016)... 22, 2016 Research and Markets has announced ... report to their offering. ... from $29.3 billion in 2013. The market is expected to grow ... 2015 to 2020, increasing from $50.6 billion in 2015 to $96.6 ... during the forecast period (2015 to 2020) are discussed. As well, ...
Breaking Biology Technology:
(Date:5/20/2016)... , May 20, 2016  VoiceIt is ... partnership with VoicePass. By working together, ... experience.  Because VoiceIt and VoicePass take slightly different ... engines increases both security and usability. ... excitement about this new partnership. "This ...
(Date:5/12/2016)... 2016 WearablesResearch.com , a brand of ... results from the Q1 wave of its quarterly wearables ... consumers, receptivity to a program where they would receive ... insurance company. "We were surprised to see ... Michael LaColla , CEO of Troubadour Research, "primarily because ...
(Date:5/3/2016)...  Neurotechnology, a provider of high-precision biometric identification ... Identification System (ABIS) , a complete system for ... can process multiple complex biometric transactions with high ... face or iris biometrics. It leverages the core ... MegaMatcher Accelerator , which have been used in ...
Breaking Biology News(10 mins):